ClinicalTrials.gg
RecruitingNCT07327593Updated Nov 10, 2026

Exercise Induced Hypoalgesia in Pain-free Stroke and Healthy Populations: a Cohort Study

An interventional study of Cardiovascular training in Stroke, Pain and Exercise Induced Hypoalgesia, sponsored by Neuron, Spain. Recruiting at 2 sites in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Neuron, Spain · Not applicable, Interventional, and Treatment

How we know

Updated Nov 10, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 323 studies in Stroke with a site in Spain — 73 open to participants now, 91 under way, 6 of them phase 3. Stroke · Spain.

Planned enrollment
135th of 246
60 · median 70
Started
2027
the only one that year
No phase
159 of 323
50 open now
Primary completion
2027-09
later than 65 of 90 live
Registered
297th of 323
by date

Among the 323 studies in Stroke with a site in Spain, this one is the 135th largest by planned enrollment of the 246 interventional ones that give a count, is the only one that started in 2027, is one of 159 with no phase, reaches primary completion later than 65 of the 90 other live ones, and was the 297th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

73 of the 323 studies in Stroke with a site in Spain are open now. Recruiting first, the newest first:

67 more — sign in →

All 73 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 323 studies in Stroke with a site in Spain, or all of them as a file.
02

Study summary

Exercise has shown multiple beneficial effects in both healthy and post-stroke populations. One of these is the acute reduction in sensitivity to painful stimuli, called exercise-induced hypoalgesia (EIH). This phenomenon has been studied since 1979 and has shown improvements in pain thresholds with both aerobic and resistance training in healthy, pain-free populations and different chronic pain conditions.

Although there has been extensive research on EIH in healthy populations and those with chronic musculoskeletal pain, surprisingly little attention has been given to individuals with neurological pathologies. Chronic pain is found in more than 50% of patients after stroke, and 70% of affected individuals experience pain on daily activities. Reported prevalences of post-stroke pain (PSP) between different studies, but there is a general consensus that it is an underreported phenomenon. Patients with pain experience greater cognitive and functional decline, fatigue, depression and lower quality of life.

Multiple factors contribute to PSP, and various approaches exist to treat all the variables influencing it. This study aims to compare the effects of exercise on pain perception in healthy individuals and stroke patients without pain, using the same cardiovascular training protocol, to better understand the mechanisms of EIH and its maintenance after stroke, ultimately aiming to improve the treatment of people with stroke.

03

Conditions studied

  • Stroke
  • Pain
  • Exercise Induced Hypoalgesia

Browse trials for

Keywords

  • Stroke
  • Pain
  • Exercise induced hypoalgesia
  • Cardiovascular training
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Healthy cohort:

  • Age > 18 years
  • No neurological damage
  • No medical conditions that could affect the test

Post-stroke cohort:

  • Age > 18 years
  • Ischemic or hemorrhagic stroke (time since onset > 3 months)

Exclusion criteria

Exclusion Criteria:

Healthy cohort:

  • Any medical condition that could affect the test (respiratory, cardiovascular, metabolic diseases, for example)
  • Pain in any location, of duration > 1 week in the 3 months preceding the trial.

Post-stroke cohort:

  • Unable to participate in the test (no possibility of transfer or active pedaling)
  • Medical to cardiovascular training for any reason
  • Inability to follow instructions or communicate sensations during training
  • Other neurological pathology, cardiac pathology (unstable angina, arrhythmias, aortic or left ventricular problems, myocarditis, pericarditis), pulmonary pathology that affects the test (pulmonary embolisms, pulmonary hypertension, etc.), renal or metabolic problems (severe renal dysfunction, uncontrolled diabetes, etc.), acute infection or fever, neurosurgery within 6 weeks prior to inclusion in the study
  • Pain in any location, lasting > 1 week in the 3 months prior to the trial.
  • Use of beta-blockers, antidepressants, or any medication that may alter heart rate measurements
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Healthy cohort

    Age \> 18 years; no neurological damage; no medical conditions that could affect the test; no pain of duration \> 1 week in the 3 months preceding the enrollment. No serious medical conditions. First, pressure pain thresholds and conditioned pain modulation will be assessed. Then, participants will conduct a cardiovascular training for 30 minutes, and will be reassessed inmediately post-training and 30 minutes after.

    Other: Cardiovascular training

  • Experimental
    Post-stroke pain free cohort

    Ischemic or hemorrhagic stroke (\> 3 months); older than 18 years old; of duration \> 1 week in the 3 months preceding the enrollment. No other serious medical conditions. Post-stroke participants will get the same study protocol than healthy cohort.

    Other: Cardiovascular training

Interventions

  • OtherCardiovascular training

    The cardiovascular training protocol will consist of a 5-minute warm-up aimed at reaching 70% of maximum heart rate (MHR) followed by 20 minutes of sustained work at this intensity (since maintaining this intensity is difficult, especially in the stroke cohort, we will allow for a margin of ±2-3% of MHR and provide feedback to increase or decrease the heart rate). We will aim to keep the heart rate below 73% of maximum heart rate, maintain blood pressure within safe ranges, and keep the effort level between 14/20 and 16/20

06

What researchers measure

Primary outcomes

  1. Pressure pain thresholds

    Pressure pain thresholds (PPT) are the most used pain sensitivity measure for these paradigms, and represent a static measure of pain, indicating the basal state of pain perception. It is usually measured with an algometer, which is pressured into the body of the participant, who is informed to warn in the moment when pressure starts to be painful. EIH has shown little differences between local and general effects, so we will measure PPT in both rectus femoris (local effects) and first dorsal interosseous (general effects), marking the exact points for ensuring the replicability of the measure after the exercise program. In the post-stroke cohort, this assessment will be performed on the non-paretic side, so that the possible loss of sensitivity due to the condition does not influence the measurements.

    Time frame: Before the cardiovacular training, inmediately after the training, and 30 minutes after

  2. Conditioned pain modulation

    Conditioned pain comulation (CPM) is the terminology used to describe the effect of endogenous pathways to enhance or diminish the afferent noxious stimuli. For this assessment the "cuff test" methodology will be carried out over the healthy arm of post-stroke participants. This methodology employs a test stimulus (TS) using pressure pain threshold measurement. Subsequently, an inflatable pressure cuff is applied, and its pressure is increased until the patient reports a pain sensation of 6 out of 10. While the cuff is inflated, the pressure pain threshold measurement is repeated to obtain a a conditioned stimulus (CS). The test result is then calculated by subtracting the pressures obtained on the algometer, thus calculating the CS-TS difference. CPM will be measured in the dominant side in the healthy cohort and in the healthy side in the post-stroke cohort.

    Time frame: Before the cardiovascular training, inmediately after the training and 30 minutes after

07

Study locations

2 of 2 sites recruiting
  • Neuron Madrid Río
    Madrid, Madrid 28045, Spain
    Recruiting
  • Neuron Nuevos Ministerios
    Madrid, Madrid, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All used databases (anonymized data) will be uploaded into zenodo

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2027; primary completion for Sep 2027, 5 months later.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 5 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: start Apr 2026 → Apr 2027, primary completion Sep 2026 → Sep 2027 and completion Nov 2026 → Nov 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 26, 2025
First posted
Jan 8, 2026
StartEst.
Apr 2027was Apr 2026
Primary completionEst.
Sep 2027was Sep 2026
CompletionEst.
Nov 2027was Nov 2026
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Apr 2026→Apr 2027
Nov 10, 2026
Primary completion
Sep 2026→Sep 2027
Nov 10, 2026
Study completion
Nov 2026→Nov 2027
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Start date Apr 2026→Apr 2027
    Primary completion Sep 2026→Sep 2027
    Study completion Nov 2026→Nov 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07327593
Lead sponsor
Neuron, Spain
Responsible party
Sponsor
First posted
Jan 8, 2026
Start date
Apr 2027 (estimated)
Primary completion
Sep 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Nov 10, 2026

Study contacts

Alejandro Herrera Rojas, Physical Therapist
Contact
aherrerar2003@gmail.com
+ 34 640944777
Alfredo Lerín Calvo, Physical Therapist
Contact
alerin@neuronrehab.es
+ 34 620187457
Alejandro Herrera Rojas, Physical Therapist
principal investigator · Neuron, Spain

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion